TABLE 4.

Treatment outcome in the three cohorts relative to COVID‐19 in Basic MHC and Specialized MHC

	Relative to COVID‐19
	Prior		Partially		Entirely
B‐MHC	M	SD	M	SD	M	SD	F(2,1385)	p	Contrast
Pretest T	73.1	11.2	71.5	10.2	71.8	10.9	0.10	.91	1 = 3, 2 = 3
Post‐test T	64.7	14.4	63.0	12.4	63.6	13.4
	N	%	N	%	N	%	χ 2(6)	p
Recovered	168	23.3	58	25.3	85	19.4	5.92	.43
Improved	247	34.3	70	30.6	167	38.0
Unchanged	248	34.4	84	36.7	155	35.3
Deteriorated	57	7.9	17	7.4	23	7.3

	Relative to COVID‐19
	Prior		Partially		Entirely
S‐MHC	M	SD	M	SD	M	SD	F(2)	p	Contrast
Pretest T	75.4	11.3	75.7	10.3	75.5	10.5	0.62	.54	1 = 3/2 = 3
Post‐test T	65.1	13.7	66.1	12.8	65.6	14.1
	N	%	N	%	N	%	χ 2(6)	p
Recovered	118	19.8	61	17.2	22	16.4	4.78	.57
Improved	269	45.1	163	45.9	88	50.7
Unchanged	162	27.1	109	30.7	37	27.6
Deteriorated	48	8.0	22	6.2	7	5.2